Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
Logan Hamilton, Freelance Writer, shared a post on LinkedIn:
“Vaccine hesitancy often grows from misleading or conspiratorial claims.
Yet, rare vaccine side effects can still occur.
Previous research confirmed dangerous blood clots after some COVID-19 vaccinations. These clots appeared only after administration of adenovirus-based COVID-19 vaccines.
Scientists have now identified a likely cause of these symptoms, known as vaccine-induced thrombocytopenia and thrombosis (VITT). The team discovered a mutated antibody gene that causes VITT symptoms.
This gene was delivered by adenovirus COVID-19 vaccines. Results showed the mutation triggered rare but dangerous blood clotting.
VITT is extremely rare among vaccinated individuals. It occurred in about one in 200,000 recipients. Only adenovirus-based COVID-19 vaccines showed this risk. mRNA COVID-19 vaccines did not show the same pattern.”
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026
-
Jul 23, 2026, 04:42Camilla Oriani: A Memorable First ISTH 2026 in Paris